Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00278759
Other study ID # C05-0501
Secondary ID
Status Completed
Phase N/A
First received January 16, 2006
Last updated February 17, 2009
Start date December 2005
Est. completion date December 2007

Study information

Verified date August 2008
Source University of British Columbia
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

Acute respiratory tract infections are among the most common problems of childhood, particularly among infants and children younger than 3 years, and account for most antibiotic prescriptions to children. Most of these infections are self-limited and do not require medical intervention; however, the symptoms overlap significantly with those of severe viral or bacterial infections. At the hospital Emergency Department (ED), medical assessment, prescription of antibiotics (unnecessarily if the infection is viral), and a series of investigations (e.g., blood work, X-rays) often take place before a decision on patient management and possible hospital admission can be made. Such procedures lead to intense use of human health resources (nursing, laboratory and radiology staff) and hospital facilities.

The literature suggests that a prompt single viral diagnosis improves decision-making. To our knowledge, no-one has performed a controlled trial to examine the impact of a rapid, multi-viral detection test like VIRAP, or the impact of the timing of such a test, on management of children with flu-like illnesses in the ED.

Our objective is to determine if use of our new viral detection program, VIRAP, for rapid testing for viral respiratory infections right after triage will improve patient management and resource use in the ED. We will test the hypothesis that availability of VIRAP at triage to support rapid diagnosis of viral infection in children at BCCH will (i) reduce the waiting time in the ED; (ii) improve decision making regarding diagnostic investigations and specimen collection; and (iii) decrease antibiotic prescriptions.

Study completed and manuscript accepted for publication in the Journal of Pediatrics.


Description:

Description of Project:

Background: Acute viral respiratory tract infections are among the most common infectious problems of childhood during the first five years of life, particularly among infants younger than 2 years of age. Although the majority of these infections does not require medical attention and are self-limited in nature, worried parents commonly bring their children to the emergency department (ED) for evaluation (average 2500 children/winter). EDs are choke points in the health care system, especially at the peaks of the annual influenza season and respiratory syncytial virus (RSV) season. Without a prompt specific viral diagnosis in a child presenting to the ED with a febrile respiratory illness, after being seen by a physician, a child may have to undergo a constellation of precautionary diagnostic tests (septic work up, CXR) and be prescribed antibiotics unnecessarily. These interventions lead to prolonged ED stays (average 180min +/-120 min), intense use of human health resources (nursing, laboratory and radiology staff) resulting in significant cost both direct and indirect to the health care system, as well as time lost to the children and their families and contribute to antimicrobial resistance. The precise etiology of these viral infection episodes can be determined through the use of rapid screening program such as VIRAP (nasopharyngeal washing for rapid direct viral antigen detection via immunofluorescence). At the moment VIRAP is a physician ordered test, done only after the child has been seen by the physician, usually after the child has already been waiting for a significant length of time, then has to wait further for the results of the test.

Hypothesis: Rapid diagnosis of viral infection through VIRAP initiated by a nurse at triage wit results available for ED physician time of assessment may influence decision making with respect to additional investigations therefore reduce the amount of waiting time in the ED, as well as decrease antibiotic prescriptions. This would ultimately result in improved effectiveness of service provision for children with febrile respiratory illnesses and in turn shorten waiting time for all children in the ED. Health care cost reduction by minimising unnecessary diagnostic tests being performed and antibiotic prescription are also expected.

Study design: We propose to conduct a single centre, open label, randomized controlled trial comparing outcomes of patients undergoing VIRAP at triage vs routine ED admission protocol. During the months of December 2005 to April, and again Dec2006 to April 2007, eligible patients based on our inclusion and exclusion will be enrolled at triage and randomized in a 1:1 ratio to either undergo NPW for VIRAP and have the result available to the treating physician at time of assessment or routine admitting protocol to the ED and await physician assessment without prior investigation.

Criteria: Patients age 3-36 months admitted to the BCCH ED with fever(≥38.5 0C measured in ED or documented by the accompanying parent) and at least one of: cough, runny nose, nasal congestion and sore throat will be eligible for enrolment. Excluded from the study will be patients who are immuno-compromised, who have underlying chronic severe respiratory conditions (cystic fibrosis, bronchopulmonary dysplasia) or chronic heart conditions (uncorrected cyanotic heart lesions, prosthetic valves), who have had prior assessment in our ED department for the current illness. Only one child per family can be enrolled.

End points: The duration of stay in ED (from assessment to discharge, including time waiting for investigations and review of results by the physician) is the primary endpoint. Secondary endpoints include whether any investigations following the assessment (blood test, radiographs or urine tests) were ordered and whether study patients were prescribed antibiotics.


Recruitment information / eligibility

Status Completed
Enrollment 275
Est. completion date December 2007
Est. primary completion date December 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 3 Months to 36 Months
Eligibility Inclusion Criteria:

- Admitted to the BCCH ED with fever (=38.5 0C) and one or more of the following:

- cough,

- runny nose,

- sore throat, or

- congested nose.

Exclusion Criteria:

Excluded from the study will be patients who are:

- immuno-compromised,

- have chronic severe respiratory conditions (cystic fibrosis, bronchopulmonary dysplasia),

- chronic heart conditions or

- who is in severe distress requiring immediate care or resuscitation, or

- have had prior assessment in our ED department for the current illness.

Only one child per family can be enrolled.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Procedure:
Nasopharyngeal washing for viral antigen detection by immunofluorescence initiated early in ED visit.
See Detailed Description.

Locations

Country Name City State
Canada Children's and Women's Health Centre of BC Vancouver British Columbia

Sponsors (2)

Lead Sponsor Collaborator
University of British Columbia Michael Smith Foundation for Health Research

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Length of Emergency Department visit (from initial physician contact to discharge from Emergency Department) Unspecified No
Secondary Rate of antibiotic prescription in Emergency Department. Unspecified No
Secondary Rate of ancillary tests performed in Emergency Department. Unspecified No
See also
  Status Clinical Trial Phase
Recruiting NCT05359770 - Association of Inspiratory Muscle Training With HD-tDCS for Assistance to Patients With Long Covid-19 N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Withdrawn NCT00800696 - Preventive Oral Care N/A
Completed NCT01009619 - Azithromycin in Bronchiolitis Obliterans Syndrome Phase 4
Completed NCT04102644 - Limiting Adverse Birth Outcomes in Resource-Limited Settings
Not yet recruiting NCT05047666 - COVID-Like Illness Respiratory Pathogens. A Prospective Cohort on the COVID-19 Post-acute Condition
Active, not recruiting NCT00969800 - Test of a Preventive Effect of a Deodorant Device Against Respiratory Infections N/A
Completed NCT05683951 - Clinical Trial to Evaluate the Efficacy and Safety of DWKH Phase 3
Withdrawn NCT02981550 - Infection Detection by Breath Analysis N/A
Completed NCT03064659 - Driving Pressure And EFL in Adult Cardiac Surgery N/A
Recruiting NCT05860387 - Early Diagnosis of Invasive Lung Aspergillosis
Completed NCT03726853 - The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497 Phase 2
Completed NCT01102374 - Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents Phase 2
Completed NCT00758914 - Vitamin E and Infection in the Elderly N/A
Recruiting NCT05904223 - Effect of IN Hospital PCR Based Assessment of Patients With Lower Respiratory Tract Infections on LEngth of Stay N/A
Recruiting NCT06390878 - Nationwide Research on the Rewilding of Kindergarten Yards N/A
Completed NCT03540706 - Impact of the Use of CRP on the Prescription of Antibiotics in General Practitioners N/A
Completed NCT04318691 - Netosis in Determination of Respiratory Infection Severity
Recruiting NCT04581486 - Effectiveness of an Optimal-Massive Intervention in Older Patients With Dysphagia N/A
Completed NCT01967628 - Human Lung Responses to Respiratory Pathogens Phase 1/Phase 2

External Links